Approved for Bivalirudin for injection is indicated for use as an anticoagulant for use in patients undergoing percutaneous coronary intervention (PCI) including patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.. Bivalirudin directly inhibits thrombin by specifically binding both to the catalytic site and to the anion-binding exosite of…
Loading full data from Know Your Drugs Institute…